Timothy K Turkalo
Overview
Explore the profile of Timothy K Turkalo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Erdmann-Pham D, Batra S, Turkalo T, Durbin J, Blanchette M, Yeh I, et al.
Nat Commun
. 2023 Nov;
14(1):7111.
PMID: 37932252
Chromosomal rearrangements can initiate and drive cancer progression, yet it has been challenging to evaluate their impact, especially in genetically heterogeneous solid cancers. To address this problem we developed HiDENSEC,...
2.
Turkalo T, Maffia A, Schabort J, Regalado S, Bhakta M, Blanchette M, et al.
Nat Commun
. 2023 Feb;
14(1):939.
PMID: 36805596
Alternative Lengthening of Telomeres (ALT) is an aberrant DNA recombination pathway which grants replicative immortality to approximately 10% of all cancers. Despite this high prevalence of ALT in cancer, the...
3.
Merkes C, Turkalo T, Wilder N, Park H, Wenger L, Lewin S, et al.
PLoS One
. 2015 Jan;
10(1):e0116627.
PMID: 25617839
Ewing sarcoma is the second most common skeletal (bone and cartilage) cancer in adolescents, and it is characterized by the expression of the aberrant chimeric fusion gene EWS/FLI1. Wild-type EWS...
4.
Park H, Turkalo T, Nelson K, Folmsbee S, Robb C, Roper B, et al.
Cell Cycle
. 2014 Dec;
13(15):2391-9.
PMID: 25483190
Ewing sarcoma is a malignant bone cancer that primarily occurs in children and adolescents. Eighty-five percent of Ewing sarcoma is characterized by the presence of the aberrant chimeric EWS/FLI1 fusion...